Raw Lyophilized Powder 5mg 10mg Vials/Nad+

Name: Raw Lyophilized Powder 5mg 10mg Vials/Nad+
Brand: Tianjin Jason Import and Export Co., Ltd.
SKU: 2123034722

Tianjin, ChinaTianjin Jason Import and Export Co., Ltd.

US$10.00

1-99 Vial

US$9.00

100-999 Vial

US$8.00

1,000+ Vial

Product specifications

Dosages

Product profile

Customization

Available

State

Solid

Appearance

White Powder

Model NO.

JS30

Production

10000vials/Week

Logo

with Labels

Purity (HPLC)

>99%

Solubility

Freely Soluble in Water

pH Value

7.0 ~ 9.0 (C=5mg/Ml)

Transport Package

Paper Boxes or Cartons

Specification

5mg/10mg

Trademark

Origin

China

Production Capacity

10000vials/Week

Company profile

ODM ServicesOEM ServicesFast DeliveryLow MOQ

Tianjin Jason Import and Export Co., Ltd.

Tianjin, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Minor Customization CertifiedExport Year: Less than 1 year CertifiedNearest Port: Tianjin PortAverage Response Time: ≤2.43h

AI-Powered supplier vetting

SummaryTianjin Jason Import and Export Co., Ltd. is a China-based trading company established in 2025 with five employees and a stated 175.0 m² manufacturing plant. It offers NAD+ and Pidotimod and operates in health, medicine, and chemicals. The supplier reports ODM and popular-brand OEM capabilities and minor customization, but has limited documented R&D infrastructure: one R&D engineer assigned to after-sales, no patents, no private molds, no SDK, and no available design-control documentation. Quality and service systems are weakly documented, with no written corrective-action or complaint-handling procedures and zero stated quality-control test equipment. It reports OEM cooperation with well-known brands, but no customer names or verifiable case details are provided. Audit information identifies CTI and a report period from 2025-09-29 to 2026-09-28, while the evaluation result is recorded as 0 without explanation.

Supplier typeThe supplier is identified as a China-based limited company and trading company, with business activities covering chemical products, raw materials, pharmaceutical intermediates, and related research and development. It is not part of a larger company group and has five employees.

After-Sales capabilityThe only stated R&D engineer responsibility is after-sales, but the supplier has no written corrective and preventive action procedures or records and no written customer-complaint handling procedures or records. This explicitly indicates deficiencies in documented after-sales and complaint-management processes.

R&D capabilityInnovation evidence is limited: the supplier launched no new products in the past year, has one R&D engineer assigned to after-sales, holds zero stated R&D patents, has no private-mold design capability, and lacks an SDK. Its business scope mentions research and development activities, but the available records do not demonstrate strong product innovation capability.

Production capacityThe supplier reports a 175.0 m² manufacturing plant and offers chemical raw materials, but is classified as a trading company with five employees. Quality-control capacity is weakly evidenced because the stated quantity and size of quality-control test equipment is 0, while quality assurance and traceability status are unknown.

Customization capabilityThe supplier explicitly reports minor customization capability and confirms ODM service availability, providing direct evidence of some design and customization support. However, the lack of private-mold capability and design-control documentation limits the demonstrated depth of customization.